NIH director Francis Collins, in an interview with C-SPAN’s “Newsmakers” program, said that the agency would issue a “Proposed Rule” in January or February that will seek to prevent pharmaceutical companies from ghostwriting studies for researchers and require drug makers and other medical companies to disclose financial relationships with NIH-funded scientists and institutions via publicly accessible websites.


Stories Feed

Recent Comments
Introduction to Sports-related Health Care